SCHEMBL4583984

SCHEMBL4583984

CC(C)n1cc(C(=O)/C=N/O)ccc1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
PTGDR2 Q9Y5Y4 4/20 0.34
HCAR3 P49019 1/20 0.33
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
HTT P42858 2/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4583989 1.00 PTGS2 (0.35) PTGS2ADORA2AADORA1PTGDR2HCAR3
SCHEMBL4584613 0.79 ALDH1A1 (0.47) ALDH1A1LMNAHTTMAPTHPGD
SCHEMBL4584616 0.79 ALDH1A1 (0.47) ALDH1A1LMNAHTTMAPTHPGD
SCHEMBL3159104 0.76 HCAR3 (0.49) PTGS2PTGDR2HCAR3ALDH1A1MAPT
SCHEMBL4583848 0.76 PTGS2 (0.40) PTGS2ADORA2AADORA1PTGDR2HCAR3
SCHEMBL4583993 0.75 PTGS2 (0.32) PTGS2ADORA2AADORA1PTGDR2HCAR3
SCHEMBL28251574 0.75 PARP10 (0.42) PTGS2ADORA2AADORA1PTGDR2HCAR3
SCHEMBL12890137 0.72 LMNA (0.48) ALDH1A1LMNAHTTMAPTHPGD
SCHEMBL5152449 0.71 KDM4E (0.32) ALDH1A1HPGDFAAH
SCHEMBL22861795 0.69 CA12 (0.49) ALDH1A1LMNAHTTMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407961-B2 Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2008-08-05 US disclosed
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof ADORA2A, P2RX5, ADORA1 PTGS2 379/4885ADORA2A 1/4885ADORA1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.